Fig. 10From: Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinomaImmunotherapy and drug sensitivity. a Tumor immune dysfunction and exclusion (TIDE) algorithm analysis for high-risk and low-risk groups. *Represents statistically significant differences. Observed the drug sensitivity of b CX-5461, c Tipifarnib, d Bexarotene, e 5-Fluorouracil, f Midostaurin, g Vinorelbine, h Etoposide, and i DoxorubicinBack to article page